| Mar'18 | Dec'17 | Sep'17 | Jun'17 | Mar'17 | Dec'16 | Sep'16 | Jun'16 | Mar'16 | Dec'15 | Sep'15 | Jun'15 | Mar'15 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flows from Operating Activities: | ||||||||||||
Net loss | ||||||||||||
-2,081 | -2,113 | -114 | -116 | -157 | -242 | -355 | -547 | -596 | -473 | 0 | 0 | 0 |
Adjustments to reconcile net loss to net cash used in operating activities: | ||||||||||||
Interest earned on Trust Account | ||||||||||||
171 | 182 | 172 | 141 | 105 | 80 | 56 | 36 | 18 | 3 | 0 | 0 | 0 |
Changes in operating assets and liabilities: | ||||||||||||
Prepaid expenses | ||||||||||||
-42 | -3 | -6 | -19 | -22 | -46 | -53 | -62 | -35 | 50 | 0 | 0 | 0 |
Accounts payable and accrued expenses | ||||||||||||
2,001 | 2,009 | 2 | -9 | -18 | 69 | 36 | 130 | 166 | 79 | 0 | 0 | 0 |
Net cash used in operating activities | ||||||||||||
0 | - | - | - | 0 | - | - | - | - | - | - | - | - |
Accrued formation and offering costs | ||||||||||||
- | - | - | - | - | - | - | - | - | 80 | 0 | 0 | 0 |
Net cash used in operating activities | ||||||||||||
- | - | - | - | - | - | - | -391 | -412 | -368 | 0 | 0 | 0 |
Cash Flows from Investing Activities: | ||||||||||||
Investment of cash held in Trust Account | ||||||||||||
608 | 672 | 607 | 623 | 369 | 200 | 100 | 0 | 0 | 43,642 | 0 | 0 | 0 |
Cash withdrawn from Trust Account | ||||||||||||
26,181 | 29,935 | 29,890 | 9,446 | 9,389 | 0 | 0 | 0 | 0 | - | - | - | - |
Net cash provided by investing activities | ||||||||||||
0 | - | - | - | 0 | - | - | - | - | - | - | - | - |
Net cash provided by investing activities | ||||||||||||
- | - | - | - | - | - | - | 0 | 0 | -43,642 | 0 | 0 | 0 |
Cash Flows from Financing Activities: | ||||||||||||
Advances from third party | ||||||||||||
- | 425 | 425 | 425 | 170 | 0 | 0 | 0 | 0 | - | - | - | - |
Advance from related party | ||||||||||||
0 | - | - | - | - | - | - | - | - | - | - | - | - |
Proceeds from sale of Units, net of underwriting discounts paid | ||||||||||||
- | - | - | - | - | - | - | - | - | 38,800 | 0 | 0 | 0 |
Proceeds from sale of Private Units | ||||||||||||
- | - | - | - | - | - | - | - | - | 2,950 | 0 | 0 | 0 |
Proceeds from sale of over-allotment Units, net of underwriting discounts paid | ||||||||||||
- | - | - | - | - | - | - | - | - | 2,842 | 0 | 0 | 0 |
Proceeds from sale of Unit Purchase Option | ||||||||||||
- | - | - | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
Payment of offering costs | ||||||||||||
- | - | - | - | - | - | - | - | - | 325 | 0 | 0 | 0 |
Proceeds from promissory notes - related parties | ||||||||||||
- | 255 | 220 | 265 | 265 | 230 | 0 | 0 | 0 | - | - | - | - |
Redemption of common stock | ||||||||||||
26,009 | 29,679 | 29,679 | 9,305 | 9,305 | 0 | 0 | 0 | 0 | - | - | - | - |
Net cash used in financing activities | ||||||||||||
0 | - | - | - | 0 | - | - | - | - | - | - | - | - |
Repayment of promissory notes - related parties | ||||||||||||
- | - | - | - | - | - | - | - | - | 120 | 0 | 0 | 0 |
Net cash used in financing activities | ||||||||||||
- | - | - | - | - | - | - | 0 | 0 | 44,147 | 0 | 0 | 0 |
Net Change in Cash | ||||||||||||
128 | -19 | -30 | -40 | -110 | -177 | -292 | -391 | -412 | 135 | 0 | 0 | 0 |
Supplemental disclosure of noncash investing and financing activities: | ||||||||||||
Initial classification of common stock subject to possible redemption | ||||||||||||
- | - | - | - | - | - | - | - | - | 36,445 | 0 | 0 | 0 |
Change in value of common stock subject to possible redemption | ||||||||||||
2,081 | 2,113 | -370 | -368 | -327 | -242 | -143 | -176 | -299 | 2,371 | 0 | 0 | 0 |
Reclassification of deferred offering costs to additional paid-in capital | ||||||||||||
- | - | - | - | - | - | - | - | - | - | 0 | 0 | 0 |